Educational Interventions Improve Adverse Drug Reaction Reporting

Elizabeth Chiang, MD,

Rashmi Rode, MD, FAAFP,

Arindam Sarkar, MD, FAAFP,

Baylor College of Medicine, Houston, Texas

American Family Physician. 2025;111(6):496-497.

Author disclosure: No relevant financial relationships.

This clinical content conforms to AAFP criteria for CME.

Author disclosure: No relevant financial relationships.

1.Shalviri G, Mohebbi N, Mirbaha F, et al. Improving adverse drug event reporting by healthcare professionals. Cochrane Database Syst Rev. 2024(10):CD012594.
2.Le Louët H, Pitts PJ. Twenty-first century global adr management: a need for clarification, redesign, and coordinated action. Ther Innov Regul Sci. 2023;57(1):100-103.
3.Hazell L, Shakir SAW. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385-396.
4.Alatawi YM, Hansen RA. Empirical estimation of under-reporting in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS). Expert Opin Drug Saf. 2017;16(7):761-767.
5.Putri RA, Ikawati Z, Rahmawati F, et al. An awareness of pharmacovigilance among healthcare professionals due to an underreporting of adverse drug reactions issue: a systematic review of the current state, obstacles, and strategy. Curr Drug Saf. 2024;19(3):317-331.
6.US Food and Drug Administration. MedWatch Minute for Health Care Professionals. 2022. Accessed March 30, 2025. https://www.youtube.com/watch?v=027N-gd1T1c